Company Filing History:
Years Active: 2007
Title: Kyu-Boem Han: Innovator in Vaccine Development
Introduction
Kyu-Boem Han is a notable inventor based in Taejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in vaccine development. His work focuses on improving the stability of recombinant modified Staphylococcal toxins.
Latest Patents
Kyu-Boem Han holds a patent for a method related to Staphylococcal enterotoxin SEC-SER, expression vector and host cell, production method thereof, and manufacturing method of vaccine. This invention pertains to a method of producing recombinant modified Staphylococcal toxin with enhanced stability. The process involves preparing a modified toxin with a specific amino acid sequence substitution, creating a vector for expressing the modified toxin, and culturing transformed cells with the vector. This innovative approach has potential applications in vaccine production.
Career Highlights
Kyu-Boem Han is associated with LG Chem Investment Ltd., where he continues to advance his research and development efforts. His work has been instrumental in the field of biotechnology, particularly in the development of vaccines that can combat various diseases.
Collaborations
He has collaborated with notable colleagues such as Hong-Kyun Lee and Yong-Ho Park, contributing to various projects that aim to enhance the efficacy and safety of vaccines.
Conclusion
Kyu-Boem Han's contributions to vaccine development through his innovative patent demonstrate his commitment to advancing biotechnology. His work not only showcases his expertise but also highlights the importance of collaboration in scientific research.